Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
House GOP Bill Targets Costs, Skips Subsidy Extension
Infrastructure & Management House GOP Bill Targets Costs, Skips Subsidy Extension

With a critical healthcare deadline rapidly approaching, House Republican leaders have introduced a comprehensive 111-page draft bill designed to tackle healthcare affordability through a series of market-based reforms. The legislation is being aggressively fast-tracked, with a Rules Committee

AHR Offers Investors Stability in Volatile Markets
Digital Health AHR Offers Investors Stability in Volatile Markets

In today's unpredictable financial landscape, where traditional equities face heightened volatility, astute investors are increasingly turning their attention toward alternative assets that promise both security and consistent returns. Amidst this shift, Real Estate Investment Trusts (REITs) have

Why Is the Betavoltaic Power Market Surging?
Infrastructure & Management Why Is the Betavoltaic Power Market Surging?

An extraordinary shift is underway in the world of specialized energy, where the global market for betavoltaic power is projected to more than double in value, rocketing from nearly USD 53 million in 2024 to over USD 131 million by 2032. This remarkable expansion, representing a compound annual

Is This Philips' Big Bet on AI Heart Care?
Imaging & Diagnostics Is This Philips' Big Bet on AI Heart Care?

In the intricate and high-stakes environment of the cardiac catheterization lab, where clinicians make critical decisions that can alter the course of a patient's life, the push for clearer, more comprehensive data has never been more intense. The recent acquisition of SpectraWave, an innovative

Does Epic's Data Monopoly Harm Healthcare?
Regulatory & Compliance Does Epic's Data Monopoly Harm Healthcare?

In an era where personal health information is one of the most valuable digital assets, the question of who controls this data has become a critical battleground for innovation, competition, and patient rights. The immense power wielded by the companies that create and manage electronic health

Fast Imaging Saves Brain Tissue in Stroke Patients
Imaging & Diagnostics Fast Imaging Saves Brain Tissue in Stroke Patients

In the critical minutes following an ischemic stroke, every second counts as brain cells begin to die, making the race against time the single most defining factor in a patient's outcome. A landmark study by researchers Wang, D., Liang, S., and Yue, Z. illuminates a transformative advancement in

ACOG Declares Telehealth an Ethical Imperative for OB Care
Patient Care ACOG Declares Telehealth an Ethical Imperative for OB Care

The American College of Obstetrics and Gynecology has issued a landmark declaration that fundamentally reframes the role of technology in maternal healthcare, elevating telehealth from a convenient alternative to an essential ethical obligation for practitioners. This pivotal shift is designed to

What Is the Hidden Workload in Pediatric Radiology?
Imaging & Diagnostics What Is the Hidden Workload in Pediatric Radiology?

A comprehensive 20-year retrospective analysis has uncovered a critical and largely unacknowledged issue within pediatric radiology, revealing the existence of a "hidden workload" driven by a staggering increase in the number of images generated per study. This research documents an exponential

FDA, CMS Pilot Fast-Tracks Health Tech for Medicare
Regulatory & Compliance FDA, CMS Pilot Fast-Tracks Health Tech for Medicare

A New Era of Regulatory Synergy in Digital Health The U.S. healthcare landscape is on the verge of a significant transformation as the Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) launch a pioneering joint pilot program. This initiative is designed to

Disability Groups Sue to Block Delaware's End-of-Life Law
Regulatory & Compliance Disability Groups Sue to Block Delaware's End-of-Life Law

A new Delaware law intended to offer compassionate end-of-life choices to the terminally ill has instead ignited a fierce legal battle, pitting the principle of personal autonomy against the fundamental civil rights of people with disabilities. A coalition of prominent patient and disability

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later